Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-06-17

Development of a cancer vaccine combining dna and specific glycoprotein/glycopeptide formulations of a tumour antigen

Objective

This innovative project will develop diagnostic kits using synthetic peptide Ags to detect Abs to post-translational proteins also preceding disorder symptoms not yet identified (via MOG model protein). Characterisation of native glycosylation will contribute to discover influence in Ab recognition. Molecular modelling will de- sign the best synthetic Ags for T- and B-cell response in animal models and patients affected by autoimmune diseases of nervous system (i.e. MS). These Ags will be used in a kit detecting anti-MOG Abs. A vital contribution to social objectives and to improvement of quality of life comes from a correlation study of Ab titre vs. MRI. Validation/ exploitation of a very cheap kit (compared to current costs) will be done in Clinical Units involving patients (final users). A strategic impact surrogate marker for the follow-up of disease activity will be developed only thanks to critical mass of balanced multidisciplinary competence and to dissemination of the results.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

CANCER RESEARCH UK
EU contribution
No data
Address
Lincoln's Inn Field 61
WC2A 3PX LONDON
United Kingdom

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (8)

My booklet 0 0